SANOFI (SNYNF) Financials
SNYNF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2024 | ? | ? |
| Dec. 31, 2023 | 139.8 billion | 57.6 billion |
| Sept. 30, 2023 | ? | ? |
| June 30, 2023 | 136.3 billion | 57.0 billion |
SNYNF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2024 | ? | ? |
| Dec. 31, 2023 | 5.1 billion | 312.8 million |
| Sept. 30, 2023 | ? | ? |
| June 30, 2023 | 2.6 billion | 174.0 million |
SNYNF Net Income
| Date | Net Income |
|---|---|
| March 31, 2024 | 1.2 billion |
| Dec. 31, 2023 | 2.2 billion |
| Sept. 30, 2023 | 2.7 billion |
| June 30, 2023 | 3.7 billion |
SNYNF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2024 | 9.4 billion | - | - |
| Dec. 31, 2023 | 9.6 billion | - | 2.2 billion |
| Sept. 30, 2023 | 8.5 billion | - | - |
| June 30, 2023 | 8.7 billion | - | 2.3 billion |
SNYNF Shares Outstanding
SNYNF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2024 | - | 1.9 billion | 2.8 billion | - |
| Dec. 31, 2023 | 2.3 billion | 3.9 billion | 3.2 billion | - |
| Sept. 30, 2023 | - | 1.8 billion | 2.7 billion | - |
| June 30, 2023 | 1.2 billion | 1.8 billion | 2.8 billion | - |
SNYNF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2024 | 12.0 billion | 3.7 billion |
| Dec. 31, 2023 | 25.3 billion | 9.1 billion |
| Sept. 30, 2023 | 13.4 billion | 4.1 billion |
| June 30, 2023 | 11.6 billion | 3.6 billion |
SNYNF
Price: $93
Dividend Yield: 4.07%
Forward Dividend Yield: 4.38%
Payout Ratio: 88.88%
Dividend Per Share: 4.07 USD
Earnings Per Share: 3.90 USD
P/E Ratio: 24.26
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 118.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 17
DGR3: 3.96%
DGR5: 1.52%
DGR10: 4.39%